Activist investor Politan Capital gained the 2 board seats it was searching for at medical expertise firm Masimo, defeating founder and CEO Joe Kiani and one other director, Chris Chavez, on the shareholder vote.

Masimo shares rose greater than 2% in prolonged buying and selling. Politan nominees Darlene Solomon and Invoice Jellison will be a part of Politan funding chief Quentin Koffey and former Johnson & Johnson government Michelle Brennan, who obtained board seats in a previous proxy battle final yr.

“We sit up for assembly with, studying from, and dealing along with the Healthcare and Shopper staff to make Masimo a good higher firm,” the 4 administrators mentioned in a press release after the vote on Thursday.

Politan’s nominees in whole obtained roughly twice as many votes as Kiani and Chavez, in keeping with an individual conversant in the matter who requested anonymity to debate personal info freely.

The prolonged proxy battle was marked by a fierce authorized battle. Masimo, finest recognized for its litigation with Apple over the corporate’s use of pulse-oximetry expertise within the Apple Watch, sued Politan, alleging errors in its proxy assertion. The activist, in flip, sued Masimo, claiming the corporate had manipulated the vote depend with the assistance of a robust shareholder ally.

Masimo’s effort for injunctive reduction was finally rejected, though Koffey was held in contempt of courtroom for revealing the decide’s choice whereas it was underneath seal. The victory for Politan will seemingly consequence within the departure of CEO Kiani in addition to working chief Bilal Muhsin. Kiani and Muhsin have each informed shareholders they’d stop if Kiani was ousted from the board.

WATCH: Masimo CEO on the proxy fight